Although overall cancer mortality rates are declining for Black patients, they continue to have higher mortality rates than White patients for some cancers.

Zydus Lifesciences Ltd has received USFDA approval to manufacture a generic version of Apalutamide tablets for prostate cancer treatment. The 60 mg tablets will be produced in Ahmedabad, addressing a ...

The company got the nod to manufacture and market apalutamide tablets, 60 mg, the generic equivalent of Erleada tablets, 60 mg. Shares of Zydus Lifesciences Ltd ended at ₹901.15, up by ₹7.85, or 0.88% ...

Prostate Cancer UK's Big Golf Race. Prostate Cancer UK is calling on golfers across the UK to help fund life-saving projects.

Brazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer imaging agent.

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...

Free prostate cancer screenings will be available at the Pike County Health Department at 900 S. Franklin Drive from 10 a.m. until 2 p.m. on March 22. Prostate Cancer is the second leading cause of ...

Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...

Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.

Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...

A former Dunfermline High School pupil has been celebrated for her outstanding research in the field of cancer studies.